OmniAb, Inc.
OABINasdaqIndustrials · Services-Commercial Physical & Biological Research · DE · SEC filings ↗ · Compare ⊕
View price & chart on Yahoo Finance ↗Financials
SEC XBRL · annual| FY25 | FY24 | FY23 | FY22 | FY21 | |
|---|---|---|---|---|---|
| Revenue | $18.7M | $26.4M | $34.2M | $59.1M | $34.7M |
| Operating income | −$69.0M | −$74.5M | −$69.4M | −$26.6M | −$35.6M |
| Net income | −$64.8M | −$62.0M | −$50.6M | −$22.3M | −$27.0M |
| Total assets | $300.9M | $325.6M | $375.2M | $393.1M | $304.5M |
| Total liabilities | $33.9M | $37.9M | $60.6M | $67.1M | $70.2M |
| Equity | $267.0M | $287.6M | $314.6M | $341.4M | $234.3M |
| EPS (diluted) | $-0.57 | $-0.61 | $-0.51 | $-0.26 | $-0.33 |
| Shares out. | 122.1M | 117.1M | 115.6M | 114.8M | 0 |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2025- Operating margin
- −369.5%
- Net margin
- −347.0%
- Return on equity
- −24.3%
- Return on assets
- −21.5%
- Return on capital (ROCE)
- −24.2%
- Liabilities / assets
- 11.3%
- Debt / equity
- 0.13×
- Book value / share
- $2.19
- Revenue growth (YoY)
- −29.3%
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2025- Altman Z″ (distress)
- 6.00safe
- Accruals / assets
- −9.4%clean
- Piotroski F-Score
- 2/9weak
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.
Signs
● 1 severe● 4 warning● 3 good- Filed a late-filing notice (Form NT) — missed an SEC deadline
- Operating losses (negative operating margin)
- Reported a net loss
- Revenue declined year-over-year
- Negative operating cash flow
- Conservative leverage (liabilities < 50% of assets)
- Clean earnings (low accruals)
- Altman Z″ in the safe zone
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Risk flags
late SEC filings- NT 10-Qmissed a reporting deadline ↗May 16, 2022
A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.
5%+ owners
SEC Schedule 13D / 13G · last 3 yrs- Ash X LpPassive (13G)Feb 10, 2026
- Whitefort Capital Management, LpPassive (13G)Nov 14, 2025
- Janus Henderson Group PlcPassive (13G)Aug 14, 2025
Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.
Short interest
FINRA · bi-monthly| Settlement | Shares short | Days to cover | Δ vs prior |
|---|---|---|---|
| May 15, 2026 | 4.9M | 4.3 | -6.4% |
| Apr 30, 2026 | 5.3M | 8.1 | -3.8% |
| Apr 15, 2026 | 5.5M | 11.1 | -8.2% |
| Mar 31, 2026 | 5.9M | 19.1 | +5.5% |
| Mar 13, 2026 | 5.6M | 16.1 | -2.7% |
Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.
Material events
SEC Form 8-K · most recent- Results of operationsMay 7, 2026
- Results of operationsMar 4, 2026
- Amended charter or bylawsJan 30, 2026
- Results of operationsNov 4, 2025
- Entered a material agreement · Unregistered equity sale · Regulation FD disclosureAug 25, 2025
- Results of operationsAug 6, 2025
- Shareholder voteJun 18, 2025
- Results of operationsMay 8, 2025
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗Event-driven situations (2)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.